Industrial Management Blog
Novel proprietary cannabidiol (CBD) therapeutic has been classified as an orphan medicinal product for the indication of epidermolysis bullosa (EB). Drug is ready for human…
To date, Infarmed has received 99 applications for licensing activities for the cultivation, manufacture, import and export of cannabis for medicinal purposes, but it has…
Michael Sassano Founder, Chairman & CEO Somai Pharmaceuticals -Investor, Cannabis, GMP, Pharmaceutical &Herbal Medicine https://www.linkedin.com/in/michaelsassano3/ Antonio Guedelha https://www.linkedin.com/in/antonio-guedelha-ba99317b/ In Good Manufacturing Practice…
Delta-8 THC derived from hemp is “lawful” and eligible for trademark protection, a federal appeals court ruled in a vaping dispute. The 9th Circuit Court…
Authored By: Michael Sassano & Antonio Guedelha Michael Sassano Founder, Chairman & CEO Somai Pharmaceuticals -Investor, Cannabis, GMP, Pharmaceutical &Herbal Medicine https://www.linkedin.com/in/michaelsassano3/ …
May 26, 2022 The U.S. Food and Drug Administration (FDA) has issued warning letters to four companies illegally selling unapproved animal drugs containing cannabidiol (CBD)…
MANOSTAXX Industrial Management Consulting was present at VITAFOODS 2022 at Geneve, Switzerland. Leading nutraceutical and dietary supplements event Vitafoods Europe takes place at Geneva…
Authored By: Michael Sassano & Antonio Guedelha Michael Sassano Antonio Guedelha Now that your GMP facility has been opened, it’s time to add some…
Getting a drug launch right is critical for its overall success. And many factors that contribute to lower-than-expected sales at launch can be mitigated through…
Anatomy of a Cannabis Plant By 2027, it’s projected that the legal cannabis market in the U.S. and Canada could hit $47.3 billion in size.…